MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$18,024K
Net loss
-$18,024K
Interest income
$509K
Loss from operations
-$14,294K
Change in fair value of
revenue purchase and...
$2,560K
Interest expense
$1,401K
Product revenues, net
$16,041K
Change in fair value of
term loan
$150K
Other (expense)
income
-$128K
Total operating
expenses
$30,335K
Selling, general and
administrative
$21,226K
Cost of product
revenues
$5,011K
Research and development
$4,098K
Back
Back
Income Statement
source: myfinsight.com
scPharmaceuticals Inc. (SCPH)
scPharmaceuticals Inc. (SCPH)